Pharmaceutical composition comprising HIV protease inhibiting co

Details Pharmaceutical composition comprising HIV protease inhibiting co Pharmaceutical composition comprising HIV protease inhibiting co

1995-05-04

1998-03-10

Venkat, Jyothsan

Drug, bio-affecting and body treating compositions

Preparations characterized by special physical form

Capsules

424455, 424489, 514212, 514255, 5142312, 514307, 514365, 514491, A61K 948

Patent

active

057258783

ABSTRACT:
A pharmaceutical composition is disclosed which comprises a solution of an HIV protease inhibiting compound in a pharmaceutically acceptable organic solvent comprising a pharmaceutically acceptable alcohol. The composition can optionally comprise a pharmaceutically acceptable acid or a combination of pharmaceutically acceptable acids. The solution can optionally be encapsulated in hard gelatin capsules or soft elastic gelatin capsules. The solution can optionally be granulated with a pharmaceutically acceptable granulating agent.

REFERENCES:
patent: 5142056 (1992-08-01), Kempf et al.
patent: 5206219 (1993-04-01), Desai
patent: 5354866 (1994-10-01), Kempf et al.
patent: 5484801 (1996-01-01), Al-Razzak et al.
Mimoto, et al., Chem. Pharm. Bull. 40(8) 2251-2253 (1992).

Affiliated with

Also associated with

Rating

Pharmaceutical composition comprising HIV protease inhibiting co does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical composition comprising HIV protease inhibiting co, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical composition comprising HIV protease inhibiting co will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-137280